Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies

Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies

Saved in:

Bibliographic Details
Main Authors:	Lele Sun, Cuiping Li, Tingting Gao, Zhe Liu, Yanli Hou, Wei Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Immunology
Subjects:	immune checkpoints TNFSF agonists cancer therapy autoimmune diseases immune response biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557176/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrated analysis of polytranscriptomics reveals TNFSF ligand genes in pancreatic cancer prognosis and immune regulation
by: Zhaoda Deng, et al.
Published: (2025-07-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases
by: Pankti Reid, et al.
Published: (2023-12-01)

Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
by: D. Valančius, et al.
Published: (2021-12-01)

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)

Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER
by: Xiaomeng Di, et al.
Published: (2025-07-01)

Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes
by: Hui Yang, et al.
Published: (2025-05-01)

Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome
by: Anastasia V. Poznyak, et al.
Published: (2025-08-01)

Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue
by: João Panão-Costa, et al.
Published: (2025-06-01)

C1QBP promotes apoptosis of goat fetal turbinate cells via inhibiting the expression of TRIM5 or TNFSF10
by: Qiuyun Li, et al.
Published: (2025-05-01)

Immune hemolytic anemia associated with the use of immune checkpoint inhibitors: a scoping review
by: Juan-Manuel Hernandez-Martinez, et al.
Published: (2025-07-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01)

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Immune Checkpoints Mediate Tumor Immune Regulation  through Metabolic Pathways
by: Weiguang DU, et al.
Published: (2025-03-01)

Challenges and advances of immune checkpoint therapy
by: Lingyu Li, et al.
Published: (2024-12-01)

A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
by: Le Xu, et al.
Published: (2025-12-01)

Patient-specific HLA-I subtypes predict response to immune checkpoint blockade
by: Kyrillus S. Shohdy, et al.
Published: (2025-12-01)

Successful Dostarlimab Rechallenge Following Pembrolizumab‐Induced Autoimmune Hemolytic Anemia: A Case Report
by: Zaid Khamis, et al.
Published: (2025-08-01)

Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
by: Susan Costantini, et al.
Published: (2025-04-01)

Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment
by: Xiaoye Shi, et al.
Published: (2024-12-01)

Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms
by: Xueqian Mao, et al.
Published: (2025-06-01)

Immune checkpoint blockers and ovarian cancer
by: Chinmoy K Bose
Published: (2017-01-01)

Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
by: MariaLuisa Vigano, et al.
Published: (2025-03-01)

Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
by: Zihan Chen, et al.
Published: (2025-05-01)

Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
by: Nora Möhn, et al.
Published: (2025-12-01)

Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy
by: Estelle Tran Van Hoi, et al.
Published: (2024-11-01)

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
by: Ling Yang, et al.
Published: (2025-08-01)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
by: Assia Hijazi, et al.
Published: (2023-12-01)

Genetic and transcriptional insights into immune checkpoint blockade response and survival: lessons from melanoma and beyond
by: Jiaxin Wen, et al.
Published: (2025-04-01)

Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01)

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum
by: Nika Kotnik, MD, et al.
Published: (2025-07-01)

Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
by: Christopher Mann, MD, et al.
Published: (2025-09-01)

The Impact of Immune Checkpoint Inhibitors on Fertility Preservation and Pregnancy Outcomes
by: Agata Prokopiuk, et al.
Published: (2025-05-01)

Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects
by: Can Lu, et al.
Published: (2025-06-01)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024-12-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01)

A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity
by: Zhulu Chen, et al.
Published: (2024-10-01)